Nitroimidazooxazines and their uses in anti-tubercular therapy

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 9198913
APP PUB NO 20120028973A1
SERIAL NO

12847452

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The present invention relates to novel nitroimidazooxazines, to their preparation, and to their use as drugs for treating Mycobacterium tuberculosis and other microbial infections, either alone or in combination with other anti-infective treatments.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
GLOBAL ALLIANCE FOR TB DRUG DEVELOPMENT40 WALL STREET 24TH FLOOR NEW YORK NY 10005

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Blaser, Adrian Waitakere City, NZ 8 45
Denny, William Alexander Auckland, NZ 66 1257
Kmentova, Iveta Jahodna, SK 2 5
Ma, Zhenkun Westfield, US 64 488
Palmer, Brian Desmond Waitakere City, NZ 17 86
Sutherland, Hamish Scott Auckland, NZ 5 17
Thompson, Andrew Mark Auckland, NZ 10 699

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
11.5 Year Payment $7400.00 $3700.00 $1850.00 Jun 1, 2027
Fee Large entity fee small entity fee micro entity fee
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00